The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7964557 B1

PDF
Full Text
Expired
Date of Patent:
Jun. 21, 2011

Filed:

Mar. 22, 2006
Applicants:

Puran S. Bora, Little Rock, AR (US);

Nalini S. Bora, Little Rock, AR (US);

Henry J. Kaplan, Louisville, KY (US);

Inventors:

Puran S. Bora, Little Rock, AR (US);

Nalini S. Bora, Little Rock, AR (US);

Henry J. Kaplan, Louisville, KY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 47/00 (2006.01); A61K 49/00 (2006.01); A61P 27/02 (2006.01); C07K 7/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention provides new methods of treating wet type of age related macular degeneration by administering adiponectin (APN) or a functional fragment derived therefrom. One of the pathological complications of age related macular degeneration (AMD) is choroidal angiogenesis or choroidal neovascularization (CNV). The inventors discovered that the level of APN expression is significantly lower in the choroids of the laser-induced mouse model of choroidal angiogenesis or choroidal neovascularization (CNV) than that of the control mice and that administration of recombinant adiponectin (rAPN) or a peptide derived from the globular domain of the intact APN protein to the mouse model of CNV reduced the size of CNV significantly. These studies are the first to demonstrate the inhibitory effect of adiponectin on choroidal angiogenesis and thus provide the basis for treating a condition or disease involving angiogenesis, particularly age related macular degeneration, with administration of adiponectin.


Find Patent Forward Citations

Loading…